Related content

Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia

By Doki Kosuke   Homma Masato   Kuga Keisuke   Kusano Kazutomi   Watanabe Shigeyuki   Yamaguchi Iwao   Kohda Yukinao  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 919-926

Springer Publishing Company

Access to resources Recommend Favorite

Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia

By Doki Kosuke   Homma Masato   Kuga Keisuke   Aonuma Kazutaka   Sakai Satoshi   Yamaguchi Iwao   Kohda Yukinao  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 951-957

Springer Publishing Company

Access to resources Recommend Favorite

Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers

By Gassó Patricia   Papagianni Katerina   Mas Sergi   de Bobadilla Ramón Fernández   Arnaiz Joan Albert   Bernardo Miquel   Lafuente Amalia  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1551-1563

Future Medicine

Access to resources Recommend Favorite

The effect of mirabegron, a potent and selective β₃-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol

By Krauwinkel Walter   Dickinson James   Schaddelee Marloes   Meijer John   Tretter Reiner   Wetering Jeroen   Strabach Gregory   Gelderen Marcel  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers

By Pedersen Rasmus Steen   Damkier Per   Brøsen Kim  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 513-521

Springer Publishing Company

Access to resources Recommend Favorite